down arrow

Sirio Pharma Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003NB0
CNY
23.50
-0.09 (-0.38%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sirio Pharma Co., Ltd.
Why is Sirio Pharma Co., Ltd. ?
1
Flat results in Mar 25
  • INTEREST(Q) At CNY 24.38 MM has Grown at 355.78%
  • INTEREST COVERAGE RATIO(Q) Lowest at 328.29
  • DEBTORS TURNOVER RATIO(HY) Lowest at 5.93%
2
With ROE of 11.90%, it has a very expensive valuation with a 2.38 Price to Book Value
  • Over the past year, while the stock has generated a return of 12.01%, its profits have fallen by -11.7%
  • At the current price, the company has a high dividend yield of 2.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sirio Pharma Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Sirio Pharma Co., Ltd.
10.33%
0.21
48.57%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
20.03%
EBIT Growth (5y)
16.48%
EBIT to Interest (avg)
52.77
Debt to EBITDA (avg)
0.54
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.99
Tax Ratio
8.83%
Dividend Payout Ratio
35.93%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.28%
ROE (avg)
10.53%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.38
EV to EBIT
18.62
EV to EBITDA
10.52
EV to Capital Employed
2.04
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
2.07%
ROCE (Latest)
10.97%
ROE (Latest)
11.90%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 706.98 MM

ROCE(HY)

Highest at 13.21%

RAW MATERIAL COST(Y)

Fallen by -15.54% (YoY

-13What is not working for the Company
INTEREST(Q)

At CNY 24.38 MM has Grown at 355.78%

INTEREST COVERAGE RATIO(Q)

Lowest at 328.29

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.93%

OPERATING PROFIT(Q)

Lowest at CNY 80.04 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.45 %

PRE-TAX PROFIT(Q)

Lowest at CNY 63.3 MM

Here's what is working for Sirio Pharma Co., Ltd.
Operating Cash Flow
Highest at CNY 706.98 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost
Fallen by -15.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sirio Pharma Co., Ltd.
Interest
At CNY 24.38 MM has Grown at 355.78%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 328.29
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at CNY 80.04 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 8.45 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CNY 63.3 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Debtors Turnover Ratio
Lowest at 5.93%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."